Tebib J G, Martinez C, Granados J, Alarcon-Segovia D, Schur P H
Department of Rheumatology/Immunology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115.
Arthritis Rheum. 1989 Nov;32(11):1465-9. doi: 10.1002/anr.1780321117.
Low levels of complement receptor type 1 (CR1) on the erythrocytes of patients with systemic lupus erythematosus (SLE) may be acquired or genetically determined. Nine families with multiple cases of SLE were studied using a CR1 probe and restriction fragment length polymorphism analysis, to address this question. The absence of a significant increase in the frequency of a 6.9-kb band (previously shown to be associated with low-level CR1 on erythrocytes) suggests that this genetic marker does not play a major role in determining SLE, either in these families or in SLE patients in general.
系统性红斑狼疮(SLE)患者红细胞上补体受体1型(CR1)水平较低,可能是后天获得的,也可能由基因决定。为了解决这个问题,我们使用CR1探针和限制性片段长度多态性分析对9个有多例SLE患者的家庭进行了研究。6.9kb条带(先前已证明与红细胞上低水平CR1相关)的频率没有显著增加,这表明该基因标记在这些家庭或一般SLE患者中,对SLE的决定作用不大。